US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist
  • 2.730
  • +0.010+0.37%
Close Apr 26 16:00 ET
  • 2.710
  • -0.020-0.73%
Post 16:05 ET
491.88MMarket Cap-6204P/E (TTM)

Arbutus Biopharma Key Stats

Arbutus Biopharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 2, 2024

Revenue(YoY)

2.71M

-59.74%
EPS(YoY)

-0.11

-9.14%

Strong Buy

Mar 31, 2024

Arbutus Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.604M--
May 2, 20242024/Q1-- / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--
Nov 7, 20232023/Q36.370M / 6.405M--
Aug 3, 20232023/Q26.202M / 8.292M--
May 4, 20232023/Q19.107M / 8.234M--
Mar 2, 20232022/Q48.502M / 8.312M--
Nov 9, 20222022/Q38.009M / 12.395M--
Aug 4, 20222022/Q218.308M / 8.713M--
May 5, 20222022/Q116.148M / 5.542M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.604M--
May 2, 20242024/Q1-- / 3.682M--
Feb 29, 20242023/Q42.912M / 6.512M--
Nov 7, 20232023/Q36.370M / 6.405M--
Aug 3, 20232023/Q26.202M / 8.292M--
May 4, 20232023/Q19.107M / 8.234M--
Mar 2, 20232022/Q48.502M / 8.312M--
Nov 9, 20222022/Q38.009M / 12.395M--
Aug 4, 20222022/Q218.308M / 8.713M--
May 5, 20222022/Q116.148M / 5.542M--

Unlock Free Earnings Estimates

Arbutus Biopharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg